FDA Approves New Medications for Treating Congestive Heart Failure in Dogs

closeup of the face of an old brown and white dog, illustrating congestive heart failure in dogs

The U.S. Food and Drug Administration (FDA) has recently approved two new medications, Torsemide and a chewable tablet form of Pimomedin, for the treatment of congestive heart failure (CHF) in dogs.

This approval was announced by the American Veterinary Medical Association (AVMA), marks a significant advancement in veterinary medicine, offering new hope for dogs suffering from this debilitating condition.

Torsemide, a loop diuretic, is now approved to help manage the symptoms of CHF by reducing fluid accumulation in the body, which is a common issue in dogs with heart failure. It works by increasing the excretion of water and salt through the kidneys, thereby reducing the workload on the heart.

Pimomedin, on the other hand, is a positive inotropic agent that enhances the heart’s contractility, helping it pump blood more effectively. This important drug is now available in a generic formula as a chewable tablet. This is the same drug and dose as is in the brand name version of the drug that has been available since 2007.

Together, these medications provide a comprehensive approach to managing heart failure in canine patients.

Understanding Congestive Heart Failure in Dogs

Congestive heart failure in dogs is a serious condition where the heart is unable to pump blood efficiently, leading to an accumulation of fluid in the lungs, abdomen, or other tissues.

This condition can stem from various underlying causes, including congenital heart defects, heartworm disease, cardiomyopathy (disease of the heart muscle), or chronic valve disease, which is particularly common in older small-breed dogs.

Causes of Congestive Heart Failure in Dogs

Some of the common causes of CHF in dogs include:

  • Congenital Heart Defects: Some dogs are born with structural abnormalities in the heart that can lead to CHF.
  • Heartworm Disease: Infestation by heartworms can cause severe damage to the heart and pulmonary arteries.
  • Cardiomyopathy: Diseases affecting the heart muscle can impair the heart’s ability to function properly.
  • Chronic Valve Disease: This is a degenerative condition affecting the heart valves, commonly seen in older dogs, especially small breeds.

Clinical Signs of Congestive Heart Failure

The clinical signs of CHF can vary, but common symptoms include:

  • Coughing: Often persistent and may worsen at night.
  • Difficulty Breathing: Including rapid or labored breathing.
  • Exercise Intolerance: Dogs may tire easily or be unwilling to engage in physical activity.
  • Fluid Accumulation: Swelling in the abdomen (ascites) or legs (edema) due to fluid retention.
  • Weight Loss or Poor Appetite: A general decline in overall health and condition.

If your dog is showing signs of congestive heart failure, seek veterinary care as soon as possible. Early diagnosis and treatment can make a significant difference in managing the condition.

Talk to Your Veterinarian to See if Torsemide or Pimomedin is Right for Your Dog

The FDA’s approval of Torsemide and the Pimomedin generic formulation provides veterinarians with new tools to better manage CHF in dogs, potentially improving the quality of life and longevity of affected pets.

Pet owners are encouraged to discuss with their veterinarians whether these new medications are appropriate for their dog’s specific situation.
Each dog’s condition is unique, and a veterinarian can provide the best guidance on treatment options tailored to their individual needs.

For more detailed information, visit the AVMA news release here.


  • Dr. Wendy Wilkins DVM PhD.

    Dr. Wendy Wilkins is an experienced veterinarian and epidemiologist with over 20 years of expertise. She holds a Doctor of Veterinary Medicine (DVM) degree and a Doctorate in Epidemiology from the University of Saskatchewan. Throughout her career, Dr. Wilkins has excelled in clinical practice, academia, research, and regulatory veterinary medicine. She is a respected voice in knowledge dissemination, delivering factual information in a readable and understandable manner through articles, books, and public engagements.

    View all posts